| The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 613 | 2016 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 334 | 2020 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 242 | 2017 |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021 | 221 | 2021 |
| Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis C Zhu, KJ Kim, X Wang, A Bartolome, M Salomao, P Dongiovanni, ... Science translational medicine 10 (468), eaat0344, 2018 | 173 | 2018 |
| Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis B Cai, P Dongiovanni, KE Corey, X Wang, IO Shmarakov, Z Zheng, ... Cell metabolism 31 (2), 406-421. e7, 2020 | 171 | 2020 |
| Liver fat accumulation is associated with circulating PCSK9 M Ruscica, N Ferri, C Macchi, M Meroni, C Lanti, C Ricci, M Maggioni, ... Annals of medicine 48 (5), 384-391, 2016 | 148 | 2016 |
| Alcohol or gut microbiota: who is the guilty? M Meroni, M Longo, P Dongiovanni International journal of molecular sciences 20 (18), 4568, 2019 | 146 | 2019 |
| PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis P Pingitore, P Dongiovanni, BM Motta, M Meroni, SM Lepore, ... Human molecular genetics 25 (23), 5212-5222, 2016 | 131 | 2016 |
| The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage B Donati, BM Motta, P Pingitore, M Meroni, A Pietrelli, A Alisi, S Petta, ... Hepatology 63 (3), 787-798, 2016 | 124 | 2016 |
| miRNA signature in NAFLD: a turning point for a non-invasive diagnosis P Dongiovanni, M Meroni, M Longo, S Fargion, AL Fracanzani International journal of molecular sciences 19 (12), 3966, 2018 | 119 | 2018 |
| The role of probiotics in nonalcoholic fatty liver disease: a new insight into therapeutic strategies M Meroni, M Longo, P Dongiovanni Nutrients 11 (11), 2642, 2019 | 106 | 2019 |
| Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease S Pelusi, G Baselli, A Pietrelli, P Dongiovanni, B Donati, MV McCain, ... Scientific reports 9 (1), 3682, 2019 | 94 | 2019 |
| Genetic and epigenetic modifiers of alcoholic liver disease M Meroni, M Longo, R Rametta, P Dongiovanni International journal of molecular sciences 19 (12), 3857, 2018 | 91 | 2018 |
| Nutrition and genetics in NAFLD: the perfect binomium M Meroni, M Longo, A Rustichelli, P Dongiovanni International Journal of Molecular Sciences 21 (8), 2986, 2020 | 84 | 2020 |
| Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker GA Baselli, P Dongiovanni, R Rametta, M Meroni, S Pelusi, M Maggioni, ... Gut 69 (10), 1855-1866, 2020 | 77 | 2020 |
| Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes M Meroni, P Dongiovanni, M Longo, F Carli, G Baselli, R Rametta, ... EBioMedicine 52, 2020 | 77 | 2020 |
| Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease P Dongiovanni, M Meroni, GA Baselli, GA Bassani, R Rametta, A Pietrelli, ... Clinical science 131 (12), 1301-1315, 2017 | 67 | 2017 |
| Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? M Longo, M Meroni, E Paolini, C Macchi, P Dongiovanni Metabolism 117, 154708, 2021 | 66 | 2021 |
| The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development–a potential therapeutic target? P Dongiovanni, R Rametta, M Meroni, L Valenti Expert review of gastroenterology & hepatology 10 (2), 229-242, 2016 | 54 | 2016 |
